HUMANIGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.50% |
|
-33.33% | -83.33% |
| 12/04 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
| 08/03 | Final DIP Financing Approved for Humanigen, Inc. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 23.82T | - | - | - | - | - | |
| 8.91TCr | ||||||
| 4.09TCr | ||||||
| 3.22TCr | ||||||
| 2.51TCr | ||||||
| 1.54TCr |
- Stock Market
- Equities
- HGENQ Stock
- Charts Humanigen, Inc.
- Sector Chart
